Together, these findings suggest that the pathological increases in amyloid-β and neurofibrillary tangles that are seen in Alzheimer's disease reduce Gαq-mediated signaling events, which may have implications for the treatment of the disease. The gene discussed is GNAQ; the disease is Alzheimer disease.